RxDoctor Payments DataLook up a doctor →

Beng Fuh

Pediatric Hematology-Oncology · Greenville, NCNPI 1134339369

Payments from drug & device makers

$2,301,175in general payments, 2019–2025

Across 674 payments — averaging $3414.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$931K
  • Pfizer$604K
  • Global Blood Therapeutics, Inc.$264K
  • Daiichi Sankyo Inc.$242K
  • Bayer$93K
  • Novo Nordisk AS$66K
  • plus $101K from 10 others
$7,215in research payments, 2019–2025

Across 6 payments — averaging $1202.45 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$7K
  • Novo Nordisk Health Care AG$115

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,301,175 in reported general payments places this provider in the 95th percentile of 57 pediatric hematology-oncology providers in North Carolina.

See all pediatric hematology-oncology providers in North Carolina

Other pediatric hematology-oncology in Greenville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →